These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 9464821)
21. Soluble interleukin 6 (IL-6) receptor influences the expression of the protooncogene junB and the production of fibrinogen in the HepG2 human hepatoma cell line and primary rat hepatocytes. Igaz P; Tóth S; Rose-John S; Madurka I; Fejér G; Szalai C; Falus A Cytokine; 1998 Aug; 10(8):620-6. PubMed ID: 9722935 [TBL] [Abstract][Full Text] [Related]
22. Interleukin 6 receptor superantagonists are potent inducers of human multiple myeloma cell death. Demartis A; Bernassola F; Savino R; Melino G; Ciliberto G Cancer Res; 1996 Sep; 56(18):4213-8. PubMed ID: 8797594 [TBL] [Abstract][Full Text] [Related]
23. Novel path to activation of vascular smooth muscle cells: up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor. Klouche M; Bhakdi S; Hemmes M; Rose-John S J Immunol; 1999 Oct; 163(8):4583-9. PubMed ID: 10510402 [TBL] [Abstract][Full Text] [Related]
24. IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Mihara M; Hashizume M; Yoshida H; Suzuki M; Shiina M Clin Sci (Lond); 2012 Feb; 122(4):143-59. PubMed ID: 22029668 [TBL] [Abstract][Full Text] [Related]
25. Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy. Gaillard JP; Bataille R; Brailly H; Zuber C; Yasukawa K; Attal M; Maruo N; Taga T; Kishimoto T; Klein B Eur J Immunol; 1993 Apr; 23(4):820-4. PubMed ID: 8458373 [TBL] [Abstract][Full Text] [Related]
26. Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family. Mihara M; Kasutani K; Okazaki M; Nakamura A; Kawai S; Sugimoto M; Matsumoto Y; Ohsugi Y Int Immunopharmacol; 2005 Nov; 5(12):1731-40. PubMed ID: 16102523 [TBL] [Abstract][Full Text] [Related]
27. The soluble interleukin 6 receptor: mechanisms of production and implications in disease. Jones SA; Horiuchi S; Topley N; Yamamoto N; Fuller GM FASEB J; 2001 Jan; 15(1):43-58. PubMed ID: 11149892 [TBL] [Abstract][Full Text] [Related]
28. [Effect of IL-6/sIL-6R on ex vivo expansion of human cord blood derived CD34+ cells]. Feng JF; Zhuang M; Zhu LJ; Sheng ZL; Zhu YQ; Li CP Ai Zheng; 2004 Jun; 23(6):715-8. PubMed ID: 15191679 [TBL] [Abstract][Full Text] [Related]
29. A combination of interleukin-6 and its soluble receptor impairs sperm motility: implications in infertility associated with endometriosis. Yoshida S; Harada T; Iwabe T; Taniguchi F; Mitsunari M; Yamauchi N; Deura I; Horie S; Terakawa N Hum Reprod; 2004 Aug; 19(8):1821-5. PubMed ID: 15166129 [TBL] [Abstract][Full Text] [Related]
30. Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseases. Michalopoulou M; Nikolaou C; Tavernarakis A; Alexandri NM; Rentzos M; Chatzipanagiotou S; Cambouri C; Vassilopoulos D Immunol Lett; 2004 Jul; 94(3):183-9. PubMed ID: 15275965 [TBL] [Abstract][Full Text] [Related]
31. Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line. Nakanishi H; Yoshioka K; Joyama S; Araki N; Myoui A; Ishiguro S; Ueda T; Yoshikawa H; Itoh K Am J Pathol; 2004 Aug; 165(2):471-80. PubMed ID: 15277221 [TBL] [Abstract][Full Text] [Related]
32. How does interleukin-6 affect the membrane expressions of interleukin-6 receptor and gp130 and the proliferation of the human myeloma cell line OPM-2? Kovacs E Biomed Pharmacother; 2003 Dec; 57(10):489-94. PubMed ID: 14637393 [TBL] [Abstract][Full Text] [Related]
33. Increased copy number of the interleukin-6 receptor gene is associated with adverse survival in multiple myeloma patients treated with autologous stem cell transplantation. Kim SY; Min HJ; Park HK; Oh B; Kim TY; She CJ; Hwang SM; Kim M; Kim HK; Kim I; Yoon SS; Park S; Kim BK; Lee JH; Lee DS; Biol Blood Marrow Transplant; 2011 Jun; 17(6):810-20. PubMed ID: 21220034 [TBL] [Abstract][Full Text] [Related]
34. Role of the IL-6 classic- and trans-signaling pathways in corneal sterile inflammation and wound healing. Ebihara N; Matsuda A; Nakamura S; Matsuda H; Murakami A Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8549-57. PubMed ID: 21989726 [TBL] [Abstract][Full Text] [Related]
35. Interleukin-6 and its receptors: a highly regulated and dynamic system. Wolf J; Rose-John S; Garbers C Cytokine; 2014 Nov; 70(1):11-20. PubMed ID: 24986424 [TBL] [Abstract][Full Text] [Related]
36. Anti-human interleukin-6 receptor antibody inhibits human myeloma growth in vivo. Suzuki H; Yasukawa K; Saito T; Goitsuka R; Hasegawa A; Ohsugi Y; Taga T; Kishimoto T Eur J Immunol; 1992 Aug; 22(8):1989-93. PubMed ID: 1639101 [TBL] [Abstract][Full Text] [Related]
37. The soluble Interleukin 6 receptor: generation and role in inflammation and cancer. Chalaris A; Garbers C; Rabe B; Rose-John S; Scheller J Eur J Cell Biol; 2011; 90(6-7):484-94. PubMed ID: 21145125 [TBL] [Abstract][Full Text] [Related]
38. Sequence, expression and function of an mRNA encoding a soluble form of the human interleukin-6 receptor (sIL-6R). Lust JA; Jelinek DF; Donovan KA; Frederick LA; Huntley BK; Braaten JK; Maihle NJ Curr Top Microbiol Immunol; 1995; 194():199-206. PubMed ID: 7895493 [TBL] [Abstract][Full Text] [Related]
39. Viral Interleukin-6: Structure, pathophysiology and strategies of neutralization. Suthaus J; Adam N; Grötzinger J; Scheller J; Rose-John S Eur J Cell Biol; 2011; 90(6-7):495-504. PubMed ID: 21176991 [TBL] [Abstract][Full Text] [Related]